Jobs
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Parental Leave
•Learning Budget
•Gym
•Healthcare
•401k
•Equity
•Parental Leave
•Learning
•Gym
Required Skills
Market Access
Health Economics
HTA
Pricing & Reimbursement
Strategic Planning
Cross-functional Leadership
Stakeholder Engagement
The Senior Manager, Value & Access Pipeline is accountable for shaping and executing the Italian affiliate’s early value and access strategy for the products under its responsibility from time to time, ensuring that clinical development choices and evidence-generation plans anticipate and satisfy future Health Technology Assessment (HTA), pricing and reimbursement requirements in Italy. For its products of reference, the role provides strategic input to clinical research and cross-functional teams on endpoints, comparators, biomarkers, unmet medical need and outcomes that are likely to be pivotal for local payer value demonstration. The position also leads local disease-area readiness for emerging therapeutic areas by building robust insight on epidemiology, patient pathways, current standards of care, unmet needs, and access barriers, and translating these insights into affiliate launch readiness actions.
Early Value & Access Strategy & Clinical Development Support Early strategic support to clinical development to ensure that trial design, endpoints, comparators, and evidence generation are relevant for HTA and reimbursement in Italy.
Emerging Therapeutic Area Intelligence & Affiliate Readiness Development of deep knowledge of emerging therapeutic areas and preparation of the Italian affiliate in terms of value story, access risks, data needs, and internal capabilities.
Cross-Functional Alignment (Local–EU–Global) & Governance Coordination and alignment across local, European, and global levels on value and access activities, ensuring strategic consistency, governance, and representation of the Italian perspective.
External Stakeholder Engagement & Insight Generation Structured and compliant engagement with external stakeholders (HTA bodies, payers, clinicians, KOLs, pharmacists, academia) to gather insights on evidence expectations, access barriers, and implementation.
Evidence Planning (HEOR/RWE), Value Tools & Payer Value Story Contribution to integrated evidence planning (HEOR/RWE), development of economic models, and value tools supporting pricing and reimbursement decisions.
Minimum Education & Experience Requirements:
- Postgraduate qualification (preferred), such as a PhD, MSc in Health Economics/HTA, MBA, or specialized training in outcomes research or evidence generation.
- Minimum of 7 years of progressive experience in Market Access / Value & Access and Pricing & Reimbursement within the pharmaceutical environment, including exposure to pipeline assets (pre-launch).
- Fluency in English, both written and spoken.
- Proven track record of cross-functional leadership in a matrix organization, with effective collaboration with EU and Global teams.
- Experience engaging, either directly or through compliant insight generation, with external stakeholders (payers, HTA experts, clinicians, patient groups) and translating insights into strategic recommendations.
Job Level: Management
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Revenue Operations Business Operations Manager
Zendesk · Madison, Wisconsin, United States of America

Contract Manager, Upmarket (Dutch Speaker)
HubSpot · Remote - United Kingdom

Manager, Field Sales
Block (Square) · Los Angeles, CA, United States of America

Senior Manager, SRE & Networking
F5 Networks · 2 Locations

Sr. Technical Project Manager
F5 Networks · Bangalore (Non-SEZ)
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago